Company: IMCR
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0001671927-25-000006
Chunk: 255

Company: Immunocore Holdings plc
Filing Date: 2025-02-26
Form: 10-K
Item: Item 8
Chunk 255
---
 Coy/s/ John GollSVP, Finance and Chief Accounting Officer (Principal Accounting Officer)February 26, 2025John Goll/s/ Professor Sir John BellChairman of the Board of DirectorsFebruary 26, 2025Professor Sir John Bell/s/ Roy S. Herbst, M.D., Ph.D.DirectorFebruary 26, 2025Roy S. Herbst, M.D., Ph.D./s/ Siddharth KaulDirectorFebruary 26, 2025Siddharth Kaul/s/ Mr. Ranjeev KrishanaDirectorFebruary 26, 2025Mr. Ranjeev KrishanaDirectorFebruary 26, 2025Dr. William Pao, M.D., Ph.D./s/ Robert PerezDirectorFebruary 26, 2025Robert Perez/s/ Kristine PetersonDirectorFebruary 26, 2025Kristine Peterson/s/ Professor Sir Peter RatcliffeDirectorFebruary 26, 2025Professor Sir Peter Ratcliffe

140

Table of Contents

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

PageReport of Independent Registered Public Accounting Firm (PCAOB ID 1147)F-2Report of Independent Registered Public Accounting Firm (PCAOB ID 1118)F-4Consolidated Balance Sheets as of December 31, 2024 and 2023F-5Consolidated Statements of Operations and Comprehensive Loss for the Years Ended December 31, 2024, 2023 and 2022F-6Consolidated Statements of Shareholders’ Equity for the Years Ended December 31, 2024, 2023 and 2022F-7Consolidated Statements of Cash Flows for the Years Ended December 31, 2024, 2023 and 2022F-8Notes to the Consolidated Financial StatementsF-9

F-1

Table of Contents

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the shareholders and the Board of Directors of Immunocore Holdings plc

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheet of Immunocore Holdings plc and subsidiaries (the “Company”) as of December 31, 2024 and 2023, the related consolidated statements of operations and comprehensive loss, shareholders’ equity, and cash flows, for each of the two years in the period ended December 31, 2024, and the related notes (collectively referred to as the “financial